Chemoinformaics analysis of 1-OXO-3,4-DIHYDROISOCHROMENE-5-CARBALDEHYDE
Molecular Weight | 176.171 | nRot | 1 |
Heavy Atom Molecular Weight | 168.107 | nRig | 18 |
Exact Molecular Weight | 176.047 | nRing | 2 |
Solubility: LogS | -2.492 | nHRing | 1 |
Solubility: LogP | -0.686 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 24.4403 |
nHD | 0 | BPOL | 11.4977 |
QED | 0.42 |
Synth | 4.011 |
Natural Product Likeliness | 1.461 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.868 |
HIA | 0.705 |
CACO-2 | -5.784 |
MDCK | 0.000116402 |
BBB | 0.51 |
PPB | 0.269631 |
VDSS | 0.353 |
FU | 0.616755 |
CYP1A2-inh | 0.014 |
CYP1A2-sub | 0.093 |
CYP2c19-inh | 0.026 |
CYP2c19-sub | 0.625 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.475 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.321 |
CYP3a4-inh | 0.005 |
CYP3a4-sub | 0.037 |
CL | 1.598 |
T12 | 0.588 |
hERG | 0.01 |
Ames | 0.689 |
ROA | 0.183 |
SkinSen | 0.172 |
Carcinogencity | 0.724 |
EI | 0.008 |
Respiratory | 0.029 |
NR-Aromatase | 0.015 |
Antiviral | No |
Prediction | 0.870349 |